Clinical use of Ga-67 DFO-DAS-fibrinogen.
The clinical usefulness of 67Ga-DFO-DAS-fibrinogen, a newly developed thrombus imaging agent, was evaluated. Fifteen cases were given 2 mCi of 67Ga-DFO-DAS-fibrinogen and images were obtained up to 96 hours after injection. Abnormal accumulation of 67Ga-DFO-DAS-fibrinogen was imaged in seven cases with either venous or arterial thrombi, and no side effects were noted. These results suggested that 67Ga-DFO-DAS-fibrinogen might be a promising agent for thrombus imaging.